![](/img/cover-not-exists.png)
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Joseph J Eron, Benjamin Young, David A Cooper, Michael Youle, Edwin DeJesus, Jaime Andrade-Villanueva, Cassy Workman, Roberto Zajdenverg, Gerd Fätkenheuer, Daniel S Berger, Princy N Kumar, Anthony J RVolume:
375
Year:
2010
Language:
english
DOI:
10.1016/s0140-6736(09)62041-9
File:
PDF, 149 KB
english, 2010